IDXX vs NCSM · P/E 40, rev $2.36B vs P/E 6.6, rev $84.0M
IDEXX Laboratories Inc (IDXX) versus NCS Multistage Holdings Inc (NCSM) — a side-by-side from cached financials, not a winner call.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
NCS Multistage Holdings Inc (NCSM) is a oil & gas equipment & services company listed on US.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Latest reported NCSM revenue for 2026-06-30 was $84.0M. Net income was -$5.0M. Revenue was up 84.1% from 2026-03-31 to 2026-06-30. NCSM currently screens at market cap $122.1M and trailing P/E 6.6.
IDXX currently screens at market cap $43.08B and trailing P/E 40.2. NCSM currently screens at market cap $122.1M and trailing P/E 6.6.
Not investment advice. Open the IDXX and NCSM stock pages for the full models.
Not investment advice.